RARE
Ultragenyx·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RARE fundamentals
Ultragenyx (RARE) released its earnings on Nov 4, 2025: revenue was 160.00M (YoY +14.74%), missed estimates; EPS was -1.81 (YoY -29.29%), missed estimates.
Revenue / YoY
160.00M
+14.74%
EPS / YoY
-1.81
-29.29%
Report date
Nov 4, 2025
RARE Earnings Call Summary for Q3,2025
- $400M Royalty Financing: Strengthens balance sheet for 2026 launches, with payments deferred until 2028.
- Clinical Catalysts: UX143 Phase III data in Q4 2025/Q1 2026; GTX-102 Phase III readout in H2 2026.
- Revenue Growth: 2025 guidance of $640-670 million (14%-20% YoY), driven by Crysvita ($460-480M) and pipeline expansion.
- Profitability Path: 2027 GAAP profitability with disciplined spending and royalty proceeds.
EPS
Revenue
Revenue & Expenses
RARE has released its 2025 Q3 earnings report, with revenue of 159.93M, reflecting a YoY change of 14.65%, and net profit of -180.41M, showing a YoY change of -35.12%. The Sankey diagram below clearly presents RARE's revenue sources and cost distribution.
Key Indicators
Ultragenyx (RARE) key financial stats and ratios, covering profitability, financial health, and leverage.
Ultragenyx (RARE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ultragenyx (RARE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ultragenyx (RARE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ultragenyx (RARE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ultragenyx (RARE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Ultragenyx's management provide for the next earnings period?What were the key takeaways from Ultragenyx’s earnings call?What is the revenue and EPS growth rate for Ultragenyx year over year?What is Ultragenyx's gross profit margin?What factors drove the changes in Ultragenyx's revenue and profit?What were the key takeaways from Ultragenyx's earnings call?Did Ultragenyx beat or miss consensus estimates last quarter?What is Ultragenyx's latest dividend and current dividend yield?
